Skip to main content
ENTX logo

Entera Bio Ltd.

ENTXNASDAQHealthcareBiotechnology

$2.68Today:- (-)1Y +17.87%

As of Oct 16, 2026 close

Market cap
$139.75M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.91$4.20
Volume (live)
-
Avg. volume (3M)
583.70K

Entera Bio (ENTX) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Entera Bio had return on equity of -108.0% (down from -103.3%), debt-to-equity of 0.04 (up from 0.03), a current ratio of 6.94 (down from 7.63) and return on assets of -56.8% (down from -56.6%). A current ratio of 6.94 means current assets exceed current liabilities.

Entera Bio Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Valuation Ratios
P/E Ratio-------2.33
P/S Ratio2118.17431.40-156.95141.9154.33-69.90
P/B Ratio6.799.661.671.793.592.64-3.46
Price/Tangible Book6.799.661.671.793.592.64-2.41
Price/FCF--------3.54
Price/OCF--------3.57
Enterprise Value Ratios
EV/Revenue1919.05394.91-51.0594.5135.56-46.86
EV/EBITDA--------2.17
EV/EBIT--------2.16
EV/FCF--------2.38
Profitability & Returns
Return on Equity (ROE)-108.01%-103.34%-80.30%-76.17%-81.04%-115.46%0.00%106.50%
Return on Assets (ROA)-56.77%-56.64%-44.65%-43.06%-42.77%-52.83%0.00%-81.60%
Return on Invested Capital (ROIC)------0.00%-648.03%
Return on Capital Employed (ROCE)-83.60%-116.70%-83.30%-114.30%-53.50%-141.70%0.00%-95.23%
Leverage & Solvency Ratios
Debt/Equity0.040.030.040.010.010.06-0.00
Liquidity Ratios
Current Ratio6.947.6310.329.588.014.95-6.97
Quick Ratio3.337.4710.109.367.934.81-6.85
Efficiency Ratios
Asset Turnover0.000.02-0.010.030.030.000.04
Yield & Distribution Ratios
Earnings Yield-12.86%-12.22%-51.42%-62.15%-15.04%-56.56%0.00%42.95%
FCF Yield-8.40%-8.73%-42.38%-59.65%-11.21%-53.50%0.00%-28.22%
Buyback Yield-22.68%-29.79%-0.69%-10.23%-41.90%-51.62%--77.78%
Total Return--------77.78%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Entera Bio Financial Ratios

What is Entera Bio's return on equity?

Entera Bio's return on equity (ROE) was -108.0% for fiscal 2025 (period ended Dec 31, 2025). It was -103.3% a year earlier.

What is Entera Bio's debt-to-equity ratio?

Entera Bio's debt-to-equity ratio was 0.04 for fiscal 2025 (period ended Dec 31, 2025). It was 0.03 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition